HCPCS code J1323 — Inj, elranatamab-bcmm, 1 mg. Status: Active. Effective Apr 1, 2024. Source: CMS HCPCS Level II.

J1323

Active

Inj, elranatamab-bcmm, 1 mg

Injection, elranatamab-bcmm, 1 mg

Category: Drugs
Section: J-codes: Drugs Administered Other Than Oral Method
Effective: Apr 1, 2024
Code type: alphanumeric
OPPS Status: G — Pass-through drugs and biologicals
OPPS APC: 0708

MUE — Medically Unlikely Edits

Maximum units of J1323 Medicare will pay for one beneficiary on one date of service. Claims exceeding the MUE are denied or returned for review.

Service Type Max Units / Day
DME Supplier 0
Outpatient Hospital 76
Practitioner Services 76

Source: CMS Medicare NCCI Medically Unlikely Edits

NDC Crosswalk

National Drug Codes (NDCs) mapped to this HCPCS code.

NDC Drug Name
00069-2522-02 Elrexfio
00069-4494-02 Elrexfio

Change History

Quarterly changes published by CMS. Revisions may affect the code description, coverage, or rate — review each quarter's changes before submitting claims.

  • New Code 2024-Q2
    Inj, elranatamab-bcmm, 1 mg